Christoph Rader

Christoph Rader, Ph.D., was a professor at Scripps Research and the Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology and associate dean of the bicoastal Scripps Research graduate program. The Rader Lab’s research focused on developing and utilizing antibody display, antibody engineering, and antibody conjugation methods for improving the potency of the mABs. Dr. Rader joined a therapeutics company as Chief Technology Officer in 2023.